Home News Labiotech interview with Arthur Lahr,…

Arthur Lahr has been part of the Dutch biotech scene for over 15 years now. The former Chief Strategy Officer of Crucell, which was sold to J&J in 2011, is now leading Kiadis Pharma as it enters Phase III and approaches the market. Read here the interview with Labiotech.

Download (PDF, 400KB)